课题基金 / 基金详情

TARGETED METAL CHELATORS FOR DIAGNOSTIC IMAGING

TARGETED METAL CHELATORS FOR DIAGNOSTIC IMAGING
用于诊断成像的靶向金属螯合剂
批准号:
6350067
负责人:
MICHAEL J. WELCH
金额:
$31.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 2003-01-31

项目摘要

项目成果

MICHAEL J. WELCH的其他基金

相似基金

相关文献

中文摘要
翻译
金属放射性核素广泛用于诊断成像。 放射性同位素 镓、铟、锝和铜的元素被用于核医学 研究,而钆螯合物作为顺磁性造影剂, 与核磁共振成像(MRI)结合。 新的改进 已经设计了用于这些金属离子的螯合剂。 性能 这些新的螯合剂将预测利用分子 机械计算,将合成配体, 用物理化学方法研究金属配合物的特性 以及体内和体外生物学评价。 螯合物已经 通过使用具有供体的配体, 对特定金属具有高度选择性的基团。 充 螯合物的亲脂性将通过改变供体基团而改变 以及加入烷基和其它取代基。 金属 螯合物将用几种类型的键官能化 与蛋白质和肽共价连接。 特别强调, 给出了金属铟和铜的新配体。 稳定性 新配体的常数将被确定和金属的动力学 测量解离。 两种配体和 将测定连接到蛋白质和肽的双功能螯合物 在体外和动物模型中。 本论文将进行合成、表征和理化性质的研究 在得克萨斯A & M大学, 药物准备工作将在华盛顿进行 大学
英文摘要
Metal radionuclides are widely used in diagnostic imaging. Radioisotopes of gallium, indium, technetium and copper are used in nuclear medicine studies while gadolinium chelates act as paramagnetic contrast agents in conjunction with nuclear magnetic resonance imaging (MRI). New improved chelating agents for these metal ions have been designed. The properties of these new chelating agents will be predicted utilizing molecular mechanic calculations, the ligands will be synthesized and the characteristics of the metal complexes studied by physicochemical methods as well as in vivo and in vitro biological evaluation. Chelates have been designed for maximum thermadynamic stability by using ligands with donor groups highly selective for the particular metals. The charge and lipophilicity of the chelates will be altered by changing the donor groups as well as the addition of alkyl groups and other substituents. The metal chelates will be functionalized with several types of linkages to allow covalent attachment to proteins and peptides. Particular emphasis is being given to new ligands for the metal indium and copper. The stability constants of the new ligands will be determined and the kinetics of metal dissociation measured. The biological behavior of both the ligands and bifunctional chelates attached to proteins and peptides will be determined in vitro and in animal models. The synthesis characterization and physicochemical studies will be carried out at Texas A&M University while the in vitro and in vivo evaluation of the pharmaceutical preparations will be undertaken at Washington University.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/0883-2897(91)90128-8
发表时间: 1991
期刊: International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology
影响因子: --
作者: [Sun,Y, Mathias,CJ, Welch,MJ, Madsen,SL, Martell,AE]
通讯作者: Martell,AE
A potential new radiopharmaceutical for parathyroid imaging: radiolabeled parathyroid-specific monoclonal antibody--I. Evaluation of 125I-labeled antibody in a nude mouse model system.
一种潜在的用于甲状旁腺成像的新型放射性药物:放射性标记的甲状旁腺特异性单克隆抗体--I。
DOI: 10.1016/0883-2897(88)90110-9
发表时间: 1988
期刊: International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology
影响因子: --
作者: [Cance,WG, Otsuka,FL, Dilley,WG, Scott,RW, Davie,JM, Welch,MJ, WellsJr,SA]
通讯作者: WellsJr,SA
Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
111In-二乙烯三胺五乙酸单克隆抗体和抗体片段体内代谢物的鉴定。
DOI: --
发表时间: 1995
期刊: Cancer research.
影响因子: --
作者: [Rogers,BE, Franano,FN, Duncan,JR, Edwards,WB, Anderson,CJ, Connett,JM, Welch,MJ]
通讯作者: Welch,MJ
DOI: 10.1016/j.nucmedbio.2004.08.011
发表时间: 2004-11
期刊: Nuclear medicine and biology
影响因子: 3.1
作者: [Xiankai Sun;Joonyoung Kim;A. Martell;M. Welch;C. Anderson]
通讯作者: Xiankai Sun;Joonyoung Kim;A. Martell;M. Welch;C. Anderson
共 17 条
    Oncologic Imaging Program
    • 批准号:
      8181187
    • 项目类别:
    • 资助金额:
      $0.79万
    • 财政年份:
      2010
    • 负责人:
      MICHAEL J. WELCH
    • 依托单位:
    Animal Studies
    • 批准号:
      7536398
    • 项目类别:
    • 资助金额:
      $27.79万
    • 财政年份:
      2007
    • 负责人:
      MICHAEL J. WELCH
    • 依托单位:
    Core-Cyclotron/Radiochemistry Core
    • 批准号:
      7536399
    • 项目类别:
    • 资助金额:
      $52.07万
    • 财政年份:
      2007
    • 负责人:
      MICHAEL J. WELCH
    • 依托单位:
    Core-Cyclotron/Radiochemistry Core
    • 批准号:
      7331476
    • 项目类别:
    • 资助金额:
      $51.68万
    • 财政年份:
      2006
    • 负责人:
      MICHAEL J. WELCH
    • 依托单位:
    海外基金